Warning: members of the public are being contacted by people claiming to work for AXA Investment Managers UK Limited.  Find out more information and what to do by clicking here.

Home advantage for UK investors

  • 14 January 2021 (3 min read)

At the beginning of January, three of our UK equity portfolio managers sat down with Richard Romer Lee of Square Mile to discuss the outlook for UK investors. The team covered a variety of topics, with contributions from Chris St John (UK Mid Cap), Simon Young, (UK Equity Income) and Dan Harlow (UK small cap).

While another national lockdown had been announced the week before filming, the team remained optimistic on the UK, driven by expectations of rebound later in the year as the COVID-19 vaccination programme is ramped up. With clarity on the UK-EU trading relationship, we believe investor sentiment towards the UK should gradually improve in the year ahead, and continue to see plenty of opportunities at an underlying stock level.

Home advantage for UK investors

As well as taking questions from attendees, the team covered:

  • A review of 2020 performance
  • Reasons to allocate to the UK in the year ahead
  • The UK’s lack of technology exposure and whether this will hold back the market
  • Upcoming IPOs in 2021
  • The outlook for UK dividends
  • ESG investment in UK equities

Have our latest insights delivered straight to your inbox

SUBSCRIBE NOW
Subscribe to updates.

    Not for Retail distribution

    This document is intended exclusively for Professional, Institutional, Qualified or Wholesale Clients / Investors only, as defined by applicable local laws and regulation. Circulation must be restricted accordingly.

    This document is for informational purposes only and does not constitute investment research or financial analysis relating to transactions in financial instruments as per MIF Directive (2014/65/EU), nor does it constitute on the part of AXA Investment Managers or its affiliated companies an offer to buy or sell any investments, products or services, and should not be considered as solicitation or investment, legal or tax advice, a recommendation for an investment strategy or a personalized recommendation to buy or sell securities.

    It has been established on the basis of data, projections, forecasts, anticipations and hypothesis which are subjective. Its analysis and conclusions are the expression of an opinion, based on available data at a specific date.

    All information in this document is established on data made public by official providers of economic and market statistics. AXA Investment Managers disclaims any and all liability relating to a decision based on or for reliance on this document. All exhibits included in this document, unless stated otherwise, are as of the publication date of this document. Furthermore, due to the subjective nature of these opinions and analysis, these data, projections, forecasts, anticipations, hypothesis, etc. are not necessary used or followed by AXA IM’s portfolio management teams or its affiliates, who may act based on their own opinions. Any reproduction of this information, in whole or in part is, unless otherwise authorised by AXA IM, prohibited.

    Issued in the UK by AXA Investment Managers UK Limited, which is authorised and regulated by the Financial Conduct Authority in the UK. Registered in England and Wales, No: 01431068. Registered Office: 22 Bishopsgate, London, EC2N 4BQ. In other jurisdictions, this document is issued by AXA Investment Managers SA’s affiliates in those countries.

    Risk Warning

    The value of investments, and the income from them, can fall as well as rise and investors may not get back the amount originally invested. 

    Are you an IFA or other Professional Investor ?

    Are you a financial advisor, institutional, or other professional investor?

    This section is for professional investors only. You need to confirm that you have the required investment knowledge and experience to view this content. This includes understanding the risks associated with investment products, and any other required qualifications according to the rules of your jurisdiction.